# Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome

> **NCT00839501** · PHASE1 · TERMINATED · sponsor: **University of Rochester** · enrollment: 3 (actual)

## Conditions studied

- Andersen-Tawil Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Potassium
- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT00839501
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Unable to recruit sufficient number of participants
- **Last updated:** 2012-01-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00839501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00839501, "Effect of Potassium and Acetazolamide on People With Andersen-Tawil Syndrome". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00839501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*